MedPath

An Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia

Completed
Conditions
Schizophrenia
Registration Number
NCT01634542
Lead Sponsor
Hoffmann-La Roche
Brief Summary

This multicenter, prospective, non-interventional study will evaluate the prevalence and characteristics of patients with persistent symptoms of schizophrenia and the course of their illness over 24 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1433
Inclusion Criteria

Patients:

  • Adult patients, >/= 18 years of age
  • Diagnosis of schizophrenia according to Diagnostic and Statistical Manual for Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) or International Classification of Diseases, 10th revision (ICD-10)

Caregivers:

  • Age >/= 18 years
  • Family member or friend of the patient, who spends at least 4 hours a week with the patient
Exclusion Criteria
  • Acute psychotic exacerbation in the 3 months prior to the baseline observation (e.g. hospitalization or increased psychiatric care in order to prevent hospitalization)
  • Enrolled in an interventional study at the baseline observation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Course of illness: Change in Positive and Negative Syndrome Scale for Schizophrenia (PANSS) scoresfrom baseline to Month 24
Secondary Outcome Measures
NameTimeMethod
Frequency/characteristics (PANSS) of patients with diagnosis of schizophrenia of >/= 12 months duration before baselineat screening (approximately 18 months)
Medical resource utilization/costs24 months
Duration/severity of symptoms of schizophrenia according to Personal Social Performance Scale (PSP) / Health Related Quality of Life (HRQoL) questionnaire24 months
© Copyright 2025. All Rights Reserved by MedPath